New meds for COPD coming ?

Tobacco consumption such as cigarette smoking is already known to cause a number of negative impacts on health as well as diseases including chronic obstructive pulmonary disease. The COPD is a severe health condition along with chronic bronchitis and emphysema. The disease sufferers are likely to experience complications in breathing and depend on artificial supply of oxygen. Countless people die because of the disease, across the world.

Recently, a team of German Scientists have carried out some laboratory experiments on mice where they acknowledged that presently several drugs have sufficient potential to reverse the incapacitating effects of emphysema. However, the team is not sure to yield similar results among humans.

Simultaneously, the study pinpointed attributes of an enzyme nitric oxide syntheses and claimed that iNOS is empowered to fluctuate levels of blood pressure and can introduce some deviations in pulmonary blood vessels to cause emphysema.

“It’s a very well designed study executed to a high technical standard but we need to have some serious reservations about translation to humans”, explained an expert from the University of Melbourne’s Lung Disease Research Group, Professor Gary Anderson, while hailing people to be cautious.

In addition, Professor Anderson claimed that scientists are looking forward to generate a new medication that can be used to improve the health condition of emphysema sufferers. He also emphasized on the need of more research to estimate its impact on humans and notified that mice are blessed with higher capacity for regeneration, unfortunately humans lack this ability.

 

 

Experts express enthusiasm develop drug cure COPD